Šalis: Ispanija
kalba: anglų
Šaltinis: HMA (Heads of Medicines Agencies)
xylazine 20 mg/ml
Eurovet Animal Health
QN05CM9
Solution for injection
Xylazine
Cattle Food, Horses Food
2011-02-12
1 PART IB - 1 SUMMARY OF PRODUCT CHARACTERISTICS SEDAXYLAN 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Sedaxylan, 20 mg/ml Solution for injection, for dogs, cats, horses and cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each millilitre contains: ACTIVE SUBSTANCES: Xylazine (base) 20.0 mg Equivalent to 23.32 mg xylazine hydrochloride EXCIPIENTS: FUNCTION AMOUNT Methyl parahydroxybenzoate (E 218) preservative 1.0 mg Propyl parahydroxybenzoate (E 216) preservative 0.1 mg Propylene glycol Co solvent 8.9 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection Clear and colourless. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs, cats, horses and cattle. 4.2 INDICATION FOR USE Sedation of dogs, cats, horses and cattle. 4.3 CONTRAINDICATIONS Do not use in the later stages of pregnancy, see section 4.7 Do not use in animals with oesophageal obstruction, and torsion of the stomach, as the muscle 3 relaxant properties of the drug appear to accentuate the effects of the obstruction and because of possible vomiting. Do not use in animals with renal or hepatic impairment, respiratory dysfunction, cardiac abnormalities, hypotension and/or shock. Do not use in diabetic animals. Do not use in calves younger than 1 week of age, foals younger than 2 weeks or in puppies and kittens younger than 6 weeks. See also section 4.7. 4.4 SPECIAL WARNINGS FOR EACH TARGET SP Perskaitykite visą dokumentą